Study of Efficacy, Safety, and Tolerability of LYS006, in Patients With Mild to Moderate Ulcerative Colitis
Status:
Recruiting
Trial end date:
2023-08-18
Target enrollment:
Participant gender:
Summary
The purpose of the study is to assess preliminary efficacy, safety, and tolerability of
LYS006 in patients with mild to moderate ulcerative colitis and to determine if LYS006 has an
adequate clinical profile for further development in this indication.